Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CES2 | O00748 | 3/20 | 0.39 |
| ▸ | CES1 | P23141 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | DAO | P14920 | 1/20 | 0.39 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.39 |
| ▸ | GFER | P55789 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | GSK3B | P49841 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | DEPTOR | Q8TB45 | 2/20 | 0.36 |
| ▸ | F2 | P00734 | 1/20 | 0.36 |
| ▸ | F10 | P00742 | 1/20 | 0.36 |
| ▸ | F12 | P00748 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL404866 | 1.00 | GAA (0.43) | GAACYP2C19ALDH1A1CES2CES1 | |
| SCHEMBL404865 | 1.00 | GAA (0.43) | GAACYP2C19ALDH1A1CES2CES1 | |
| Hydrochloric Acid SCHEMBL5129627 | 0.97 | GAA (0.41) | GAACYP2C19ALDH1A1CES2CES1 | |
| Hydrochloric Acid SCHEMBL7220016 | 0.97 | GAA (0.41) | GAACYP2C19ALDH1A1CES2CES1 | |
| Hydrochloric Acid SCHEMBL7220018 | 0.97 | GAA (0.41) | GAACYP2C19ALDH1A1CES2CES1 | |
| Alcohol SCHEMBL27494925 | 0.89 | ATM (0.43) | GAACYP2C19ALDH1A1CES2CES1 | |
| Acetic Acid SCHEMBL1849523 | 0.89 | CES2 (0.46) | GAACYP2C19ALDH1A1CES2CES1 | |
| Acetic Acid SCHEMBL1849527 | 0.89 | CES2 (0.46) | GAACYP2C19ALDH1A1CES2CES1 | |
| SCHEMBL4045427 | 0.85 | SMN1; SMN2 (0.45) | ALDH1A1HPGDSMN1; SMN2GSK3BHIF1A | |
| SCHEMBL4045428 | 0.85 | SMN1; SMN2 (0.45) | ALDH1A1HPGDSMN1; SMN2GSK3BHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 454 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220202015-A1 | STABLE MICROBICIDE COMPOSITION | CHEMICREA INC. (JP) | 2022-06-30 | — | — | US | claimed |
| CN-114173563-A | Stable microbicide composition | 株式会社凯美科瑞亚 | 2022-03-11 | — | — | CN | claimed |
| CN-114149378-A | Method for preparing polysubstituted p-quinone methylated spiro-framework oxazole | 首都医科大学 | 2022-03-08 | — | — | CN | claimed |
| WO-2020246452-A1 | STABLE MICROBICIDE COMPOSITION | 株式会社ケミクレア | 2020-12-10 | — | — | WO | claimed |
| EP-0314422-B1 | N-PHENYLALKYLBENZAMIDE FUNGICIDES | DOWELANCO (US) | 1993-07-28 | — | — | EP | claimed |
| EP-0314422-A2 | N-phenylalkylbenzamide fungicides | DOWELANCO (US) | 1989-05-03 | — | — | EP | claimed |
| US-12565492-B2 | Anaplastic Lymphoma Kinase (ALK) degraders and uses thereof | TRIANA BIOMEDICINES, INC. (US) | 2026-03-03 | — | — | US | disclosed |
| US-20260042752-A1 | ANAPLASTIC LYMPHOMA KINASE (ALK) DEGRADERS AND USES THEREOF | TRIANA BIOMEDICINES INC (US) | 2026-02-12 | — | — | US | disclosed |
| US-12286439-B2 | Inhibitors of ERK nuclear translocation | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2025-04-29 | — | — | US | disclosed |
| WO-2025085347-A1 | IL4I1 INHIBITORS AND USES THEREOF | MERCK SHARP & DOHME LLC (US) | 2025-04-24 | — | — | WO | disclosed |
| CN-115710195-B | Trifluoro-olefine compound with nematicidal activity and its preparation method and use | 华东理工大学 | 2025-02-14 | — | — | CN | disclosed |
| US-20240376089-A1 | 3-HYDROXY-5-(ISOXAZOL-5-YL) PYRIDINE FORMYLGLYCINE COMPOUNDS, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | CHINA PHARMACEUTICAL UNIVERSITY (CN) | 2024-11-14 | — | — | US | disclosed |
| US-20240246937-A1 | IL4I1 INHIBITORS AND METHODS OF USE | MERCK SHARP & DOHME LLC (US) | 2024-07-25 | — | — | US | disclosed |
| EP-0334863-A1 | PROCESS FOR THE PREPARATION OF ORGANO N-HYDROXYIMIDATES. | ALLIED CORP (US) | 1989-10-04 | — | — | EP | disclosed |
| EP-0314422-A2 | N-phenylalkylbenzamide fungicides | DOWELANCO (US) | 1989-05-03 | — | — | EP | disclosed |
| WO-1988004291-A1 | PROCESS FOR THE PREPARATION OF ORGANO N-HYDROXYIMIDATES | ALLIED CORPORATION (US) | 1988-06-16 | — | — | WO | disclosed |
| US-4743701-A | Process for the preparation of organo N-hydroxyimidates | ALLIED CORPORATION (US) | 1988-05-10 | — | — | US | disclosed |
| CN-85106974-A | Ether-derivative herbicides | — | 1987-04-01 | — | — | CN | disclosed |
| US-4614813-A | Process for the preparation of N-hydroxy organo imidate compounds | ALLIED CORPORATION (US) | 1986-09-30 | — | — | US | disclosed |
| US-4581365-A | Trichloroacryloyl oxime fungicides | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1986-04-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042752-A1 | ANAPLASTIC LYMPHOMA KINASE (ALK) DEGRADERS AND USES THEREOF | ALK, NTRK1, NTRK3 | GAA 1685/4885CYP2C19 3231/4885ALDH1A1 2403/4885 |
| US-12286439-B2 | Inhibitors of ERK nuclear translocation | MAPK1, MAPKAP1, MAPKAPK2 | GAA 3589/4885CYP2C19 3302/4885ALDH1A1 2978/4885 |
| US-20240376089-A1 | 3-HYDROXY-5-(ISOXAZOL-5-YL) PYRIDINE FORMYLGLYCINE COMPOUNDS, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE | HIF1AN, HIF1A, EGLN3 | GAA 93/4885CYP2C19 519/4885ALDH1A1 1081/4885 |
| US-12565492-B2 | Anaplastic Lymphoma Kinase (ALK) degraders and uses thereof | ALK, NTRK3, NTRK1 | GAA 2291/4885CYP2C19 2064/4885ALDH1A1 2387/4885 |
| US-20240246937-A1 | IL4I1 INHIBITORS AND METHODS OF USE | IL4I1, IL4, IL2 | GAA 3303/4885CYP2C19 423/4885ALDH1A1 283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.